Operose Advisors’s MetLife MET Stock Holding History

Operose Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$170K	Buy	2,009 +9	+0.5%	+$726	0.03%	187
2026 Q1	$141K	Hold	2,000	–	–	0.03%	181
2025 Q4	$158K	Hold	2,000	–	–	0.04%	175
2025 Q3	$165K	Hold	2,000	–	–	0.04%	159
2025 Q2	$161K	Hold	2,000	–	–	0.05%	150
2025 Q1	$161K	Hold	2,000	–	–	0.05%	129
2024 Q4	$164K	Sell	2,000 -285	-12%	-$23.7K	0.06%	137
2024 Q3	$188K	Hold	2,285	–	–	0.06%	146
2024 Q2	$160K	Hold	2,285	–	–	0.06%	154
2024 Q1	$169K	Hold	2,285	–	–	0.06%	168
2023 Q4	$151K	Sell	2,285 -420	-16%	-$26.3K	0.06%	129
2023 Q3	$170K	Buy	2,705 +705	+35%	+$43.9K	0.07%	150
2023 Q2	$113K	Hold	2,000	–	–	0.05%	116
2023 Q1	$116K	Hold	2,000	–	–	0.06%	104
2022 Q4	$145K	Hold	2,000	–	–	0.08%	90
2022 Q3	$122K	Hold	2,000	–	–	0.08%	88
2022 Q2	$126K	Hold	2,000	–	–	0.09%	80
2022 Q1	$141K	Hold	2,000	–	–	0.1%	83
2021 Q4	$125K	Buy	+2,000	New	+$126K	0.1%	85

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Operose Advisors's MET Position: Q2 2026 in Review

Operose Advisors increased its MetLife (MET) stake by 0.45% in Q2 2026, buying an estimated $726 and bringing the position to 2,009 shares worth $170K. The position accounts for 0.03% of the portfolio, ranked #187.

Operose Advisors first reported a position in MET in Q4 2021 and has held it in 19 quarters since. The position peaked at $188K in Q3 2024. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Operose Advisors held 2,009 shares of MetLife worth $170K as of Q2 2026.
Operose Advisors bought 9 MetLife shares in Q2 2026, an estimated $726.
MetLife made up 0.03% of Operose Advisors's portfolio in Q2 2026, its #187 holding.
Operose Advisors first reported a position in MetLife in Q4 2021 and has held it in 19 quarters since.
Operose Advisors's MetLife position peaked at $188K in Q3 2024.
1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.